Back to results
CompletedPhase 3

ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)

NCT02136914

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Birmingham, Alabama, United States

+45 additional locations

View on ClinicalTrials.gov
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study) — TrialFind